Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

But a lot of work remains to get eligible people screened for lung cancer and expand affordable access to the targeted ...

Last year, Coskun and his team introduced a new study in “single cell spatial metabolomics,” which explores the distribution ...

More than 5,000 people in England have now been diagnosed with cancer through the NHS Targeted Lung Health Check programme.

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...

The FDA has approved FoundationOne Liquid CDx as a companion diagnostic for patients with metastatic non–small cell lung ...

Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, presented data at the International Oncolytic Virotherapy ...

The latest NHS data shows that 5,037 lung cancers have now been found in England through the programme since its launch in 2019. This includes over 700 lung cancer cancers found in Greater Manchester.

The 22nd Annual Winter Lung Cancer Conference® will explore advances in neoadjuvant/adjuvant therapies. The FDA has approved Obe-cel for R/R B-ALL, and new treatments in SCLC, lurbinectedin and ...

This data supports the potential use of RTNova to target every metastatic site in multiple oncology indications including metastatic lung cancer. RTNova is uniquely designed to overcome key ...

Louisiana residents have one of the highest lung cancer death rates in the country, even as groundbreaking treatments in ...

A new study presents a customised treatment strategy using antisense oligonucleotides (ASOs) to target EGFR mutations in ...